ProShare Advisors’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $187K | Buy |
|
|||||
|
2025
Q1 | $90K | Sell |
|
|||||
|
2024
Q4 | $111K | Buy |
|
|||||
|
2024
Q3 | $51.9K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $5K | Buy |
|
|||||
|
2022
Q2 | $5K | Sell |
|
|||||
|
2022
Q1 | $36K | Sell |
|
|||||
|
2021
Q4 | $142K | Buy |
|
|||||
|
2021
Q3 | $172K | Sell |
|
|||||
|
2021
Q2 | $266K | Buy |
|
|||||
|
2021
Q1 | $202K | Buy |
|
|||||
|
2020
Q4 | $151K | Buy |
|
|||||
|
2020
Q3 | $102K | Buy |
|
|||||
|
2020
Q2 | $547K | Buy |
|
|||||
|
2020
Q1 | $177K | Sell |
|
|||||
|
2019
Q4 | $264K | Sell |
|
|||||
|
2019
Q3 | $179K | Buy |
|
|||||
|
2019
Q2 | $211K | Sell |
|
|||||
|
2019
Q1 | $400K | Buy |
|
|||||
|
2018
Q4 | $157K | Sell |
|
|||||
|
2018
Q3 | $260K | Sell |
|
|||||
|
2018
Q2 | $305K | Buy |
|
|||||
|
2018
Q1 | $263K | Sell |
|
|||||
|
2017
Q4 | $477K | Buy |
|
|||||
|
2017
Q3 | $583K | Buy |
|
|||||
|
2017
Q2 | $333K | Sell |
|
|||||
|
2017
Q1 | $226K | Sell |
|
|||||
|
2016
Q4 | $324K | Buy |
|
|||||
|
2016
Q3 | $249K | Sell |
|
|||||
|
2016
Q2 | $244K | Buy |
|
|||||
|
2016
Q1 | $287K | Buy |
|
|||||
|
2015
Q4 | $367K | Buy |
|
|||||
|
2015
Q3 | $235K | Sell |
|
|||||
|
2015
Q2 | $269K | Buy |
|
|||||
|
2015
Q1 | $199K | Buy |
|
|||||
|
2014
Q4 | $176K | Buy |
|